Hardy et al. showed that PRL2 is overexpressed in human breast cancer tissues and in metastatic lymph nodes, and that PRL2 knockdown decreases cell migration of MDA-MB-231 and mouse mammary tumor-derived cell lines, as well as tumor progression in mice models [41]. This evidence concerns the gene PTP4A2 and breast carcinoma.